Long Term Debt Summary of Biogen Inc.

Biogen Inc.'s latest annual long term debt in 2023 was 7.18 Billion USD , up 8.68% from previous year.
Biogen Inc.'s latest quarterly long term debt in 2024 Q3 was 4.9 Billion USD , down -27.75% from previous quarter.
Biogen Inc. reported annual long term debt of 6.61 Billion USD in 2022, up 0.15% from previous year.
Biogen Inc. reported annual long term debt of 6.6 Billion USD in 2021, down -15.63% from previous year.
Biogen Inc. reported quarterly long term debt of 6.29 Billion USD for 2024 Q1, down -7.34% from previous quarter.
Biogen Inc. reported quarterly long term debt of 4.9 Billion USD for 2024 Q3, down -27.75% from previous quarter.

Annual Long Term Debt Chart of Biogen Inc. (2023 - 1989)

Historical Annual Long Term Debt of Biogen Inc. (2023 - 1989)

Year	Long Term Debt	Long Term Debt Growth
2023	7.18 Billion USD	8.68%
2022	6.61 Billion USD	0.15%
2021	6.6 Billion USD	-15.63%
2020	7.82 Billion USD	60.69%
2019	4.87 Billion USD	-17.94%
2018	5.93 Billion USD	0.03%
2017	5.93 Billion USD	-8.87%
2016	6.51 Billion USD	-0.13%
2015	6.52 Billion USD	1020.42%
2014	582.06 Million USD	-1.75%
2013	592.43 Million USD	-13.81%
2012	687.39 Million USD	-35.2%
2011	1.06 Billion USD	-0.52%
2010	1.06 Billion USD	-1.28%
2009	1.08 Billion USD	-0.48%
2008	1.08 Billion USD	1993.69%
2007	51.84 Million USD	-46.38%
2006	96.69 Million USD	122.57%
2005	43.44 Million USD	-57.36%
2004	101.87 Million USD	-88.52%
2003	887.27 Million USD	2271.75%
2002	37.41 Million USD	-51.59%
2001	77.27 Million USD	-26.01%
2000	104.43 Million USD	-3.46%
1999	108.17 Million USD	89.91%
1998	56.96 Million USD	-7.9%
1997	61.84 Million USD	-0.66%
1996	62.25 Million USD	89.65%
1995	32.82 Million USD	0.0%
1994	- USD	0.0%
1993	- USD	0.0%
1992	- USD	0.0%
1991	- USD	0.0%
1990	- USD	0.0%
1989	- USD	-100.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	6.29 Billion USD	0.03%
2024 Q1	6.29 Billion USD	-7.34%
2024 Q3	4.9 Billion USD	-27.75%
2023 Q3	7.21 Billion USD	9.5%
2023 Q2	6.58 Billion USD	-0.31%
2023 Q1	6.6 Billion USD	-0.07%
2023 FY	7.18 Billion USD	8.68%
2023 Q4	7.18 Billion USD	-0.37%
2022 Q2	6.55 Billion USD	-0.55%
2022 FY	6.61 Billion USD	0.15%
2022 Q4	6.61 Billion USD	-0.3%
2022 Q3	6.63 Billion USD	1.26%
2022 Q1	6.58 Billion USD	-0.25%
2021 FY	6.6 Billion USD	-15.63%
2021 Q2	7.63 Billion USD	-0.18%
2021 Q1	7.64 Billion USD	-2.31%
2021 Q4	6.6 Billion USD	-0.24%
2021 Q3	6.62 Billion USD	-13.27%
2020 Q3	7.83 Billion USD	-0.06%
2020 Q1	4.86 Billion USD	-0.17%
2020 FY	7.82 Billion USD	60.69%
2020 Q2	7.83 Billion USD	61.17%
2020 Q4	7.82 Billion USD	-0.08%
2019 Q4	4.87 Billion USD	0.06%
2019 Q1	6.37 Billion USD	7.46%
2019 Q2	6.37 Billion USD	-0.12%
2019 Q3	4.86 Billion USD	-23.59%
2019 FY	4.87 Billion USD	-17.94%
2018 Q1	5.92 Billion USD	-0.09%
2018 Q4	5.93 Billion USD	0.09%
2018 Q3	5.93 Billion USD	0.05%
2018 FY	5.93 Billion USD	0.03%
2018 Q2	5.92 Billion USD	-0.02%
2017 Q3	5.93 Billion USD	-0.26%
2017 FY	5.93 Billion USD	-8.87%
2017 Q1	5.95 Billion USD	-8.6%
2017 Q4	5.93 Billion USD	-0.06%
2017 Q2	5.95 Billion USD	0.02%
2016 Q4	6.51 Billion USD	-0.26%
2016 Q1	6.53 Billion USD	0.22%
2016 Q2	6.53 Billion USD	0.04%
2016 Q3	6.52 Billion USD	-0.13%
2016 FY	6.51 Billion USD	-0.13%
2015 FY	6.52 Billion USD	1020.42%
2015 Q1	580.67 Million USD	-0.24%
2015 Q2	576.2 Million USD	-0.77%
2015 Q3	6.52 Billion USD	1033.15%
2015 Q4	6.52 Billion USD	-0.12%
2014 Q4	582.06 Million USD	-0.33%
2014 FY	582.06 Million USD	-1.75%
2014 Q3	583.97 Million USD	-0.36%
2014 Q2	586.09 Million USD	-0.83%
2014 Q1	591.01 Million USD	-0.24%
2013 Q2	726.38 Million USD	2.05%
2013 Q1	711.83 Million USD	3.55%
2013 FY	592.43 Million USD	-13.81%
2013 Q4	592.43 Million USD	-14.74%
2013 Q3	694.89 Million USD	-4.34%
2012 Q4	687.39 Million USD	4.4%
2012 FY	687.39 Million USD	-35.2%
2012 Q2	641.56 Million USD	2.48%
2012 Q3	658.44 Million USD	2.63%
2012 Q1	626.01 Million USD	-40.99%
2011 FY	1.06 Billion USD	-0.52%
2011 Q3	1.06 Billion USD	-0.22%
2011 Q4	1.06 Billion USD	0.02%
2011 Q2	1.06 Billion USD	-0.25%
2011 Q1	1.06 Billion USD	-0.07%
2010 Q1	1.07 Billion USD	-0.37%
2010 FY	1.06 Billion USD	-1.28%
2010 Q3	1.06 Billion USD	-0.09%
2010 Q4	1.06 Billion USD	-0.22%
2010 Q2	1.06 Billion USD	-0.6%
2009 FY	1.08 Billion USD	-0.48%
2009 Q4	1.08 Billion USD	-0.52%
2009 Q3	1.08 Billion USD	0.02%
2009 Q2	1.08 Billion USD	0.25%
2009 Q1	1.08 Billion USD	-0.23%
2008 Q4	1.08 Billion USD	4.13%
2008 FY	1.08 Billion USD	1993.69%
2008 Q3	1.04 Billion USD	0.42%
2008 Q2	1.03 Billion USD	-2.11%
2008 Q1	1.06 Billion USD	1945.5%
2007 Q4	51.84 Million USD	3.45%
2007 FY	51.84 Million USD	-46.38%
2007 Q1	52.04 Million USD	-46.18%
2007 Q2	51.34 Million USD	-1.34%
2007 Q3	50.11 Million USD	-2.41%
2006 Q3	45.07 Million USD	1.23%
2006 Q4	96.69 Million USD	114.52%
2006 Q1	43.97 Million USD	1.23%
2006 FY	96.69 Million USD	122.57%
2006 Q2	44.52 Million USD	1.25%
2005 Q2	42.4 Million USD	-55.25%
2005 Q4	43.44 Million USD	1.21%
2005 Q1	94.75 Million USD	-6.99%
2005 FY	43.44 Million USD	-57.36%
2005 Q3	42.92 Million USD	1.23%
2004 Q3	845.7 Million USD	-2.37%
2004 FY	101.87 Million USD	-88.52%
2004 Q1	861.29 Million USD	-2.93%
2004 Q2	866.22 Million USD	0.57%
2004 Q4	101.87 Million USD	-87.95%
2003 FY	887.27 Million USD	2271.75%
2003 Q2	34.96 Million USD	-33.43%
2003 Q1	52.52 Million USD	40.41%
2003 Q3	34.16 Million USD	-2.3%
2003 Q4	887.27 Million USD	2497.32%
2002 FY	37.41 Million USD	-51.59%
2002 Q4	37.41 Million USD	-44.87%
2002 Q3	67.85 Million USD	-5.8%
2002 Q2	72.03 Million USD	-1.82%
2002 Q1	73.36 Million USD	-5.05%
2001 FY	77.27 Million USD	-26.01%
2001 Q4	77.27 Million USD	-20.47%
2001 Q3	97.16 Million USD	-1.02%
2001 Q2	98.17 Million USD	-0.88%
2001 Q1	99.03 Million USD	-5.17%
2000 FY	104.43 Million USD	-3.46%
2000 Q4	104.43 Million USD	113.9%
2000 Q3	48.82 Million USD	-1.62%
2000 Q2	49.63 Million USD	-3.19%
2000 Q1	51.26 Million USD	-52.61%
1999 Q1	56.2 Million USD	-1.33%
1999 FY	108.17 Million USD	89.91%
1999 Q4	108.17 Million USD	101.44%
1999 Q3	53.7 Million USD	-1.47%
1999 Q2	54.5 Million USD	-3.02%
1998 Q1	61 Million USD	-1.37%
1998 Q2	59.4 Million USD	-2.62%
1998 Q3	58.6 Million USD	-1.35%
1998 Q4	56.96 Million USD	-2.8%
1998 FY	56.96 Million USD	-7.9%
1997 Q1	66 Million USD	6.02%
1997 FY	61.84 Million USD	-0.66%
1997 Q2	64.3 Million USD	-2.58%
1997 Q3	63.5 Million USD	-1.24%
1997 Q4	61.84 Million USD	-2.6%
1996 Q2	51 Million USD	27.82%
1996 FY	62.25 Million USD	89.65%
1996 Q1	39.9 Million USD	21.55%
1996 Q3	60 Million USD	17.65%
1996 Q4	62.25 Million USD	3.76%
1995 Q4	32.82 Million USD	12.8%
1995 Q3	29.1 Million USD	24.89%
1995 Q1	24.2 Million USD	0.0%
1995 FY	32.82 Million USD	0.0%
1995 Q2	23.3 Million USD	-3.72%
1994 Q3	- USD	0.0%
1994 Q1	- USD	0.0%
1994 Q2	- USD	0.0%
1994 Q4	- USD	0.0%
1994 FY	- USD	0.0%
1993 Q3	- USD	0.0%
1993 Q2	- USD	0.0%
1993 Q1	- USD	0.0%
1993 FY	- USD	0.0%
1993 Q4	- USD	0.0%
1992 Q3	- USD	0.0%
1992 Q1	- USD	0.0%
1992 Q4	- USD	0.0%
1992 FY	- USD	0.0%
1992 Q2	- USD	0.0%
1991 Q3	- USD	0.0%
1991 Q4	- USD	0.0%
1991 FY	- USD	0.0%
1991 Q1	- USD	0.0%
1991 Q2	- USD	0.0%
1990 FY	- USD	0.0%
1990 Q3	- USD	0.0%
1990 Q4	- USD	0.0%
1990 Q2	- USD	0.0%
1990 Q1	- USD	0.0%
1989 FY	- USD	-100.0%
1989 Q4	- USD	0.0%
1989 Q3	- USD	0.0%

Peer Long Term Debt Comparison of Biogen Inc.

Name	Long Term Debt	Long Term Debt Difference
Amgen Inc.	63.17 Billion USD	88.621%
AstraZeneca PLC	23.22 Billion USD	69.046%
Gilead Sciences, Inc.	23.18 Billion USD	69.002%
MIRA Pharmaceuticals, Inc.	- USD	-Infinity%
Scilex Holding Company	17.03 Million USD	-42089.224%
Scilex Holding Company	17.03 Million USD	-42089.224%

Global Stocks Search

Biogen Inc. (BIIB)

Long Term Debt Summary of Biogen Inc.

Annual Long Term Debt Chart of Biogen Inc. (2023 - 1989)

Historical Annual Long Term Debt of Biogen Inc. (2023 - 1989)

Peer Long Term Debt Comparison of Biogen Inc.